Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:18 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 358 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: total hip arthroplasty Clear all

Conditions: Hip Arthrosis, Osteoarthritis, Arthritis
Interventions: Capsulectomy in Direct Anterior Total Hip Arthroplasty, Capsulotomy in Direct Anterior Total Hip Arthroplasty; Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Hip Osteoarthritis, Knee Osteoarthritis
Interventions: Educational intervention; Other
Lead sponsor: West Virginia University; Other
Eligibility: 45 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: THA
Interventions: Duloxetine, Placebo; Drug · Other
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Femoral Neck Fractures
Interventions: Hip arthroplasty, Internal fixation; Procedure
Lead sponsor: University of Southern California; Other
Eligibility: 60 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 22
States / cities: Irvine, California • Los Angeles, California • San Francisco, California + 16 more

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip
Interventions: Risk Status Optimization; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Osteoarthritis, Arthroplasty
Interventions: Ropivacaine with NaCl, Epinephrine, Morphine, Ketorolac Tromethamine, Ropivacaine; Drug
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Arthroplasty
Interventions: 4975, highly purified capsaicin, Placebo; Drug
Lead sponsor: Anesiva, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 10
States / cities: Birmingham, Alabama • Arcadia, California • Glendale, California + 7 more

Conditions: Total Hip Arthroplasty
Interventions: Total Hip Arthroplasty; Procedure
Lead sponsor: Rothman Institute Orthopaedics; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 2
States / cities: Egg Harbor, New Jersey • Philadelphia, Pennsylvania

Conditions: Osteoporosis
Interventions: Tetracycline, Demeclocycline, Total Hip Replacement; Other · Procedure
Lead sponsor: Amgen; Industry
Eligibility: 50 Years to 100 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: West Haverstraw, New York

Conditions: Hip Osteoarthritis, Hip Arthritis
Interventions: Alexis wound retractor, Standard wound retractor; Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Deep Vein Thrombosis, Pulmonary Embolism
Interventions: Enoxaparin, Apixaban, Enoxaparin-matching placebo, Apixaban-matching placebo; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 5,407 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 19
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Sacramento, California + 12 more

Conditions: Hypothermia
Interventions: Observation Of Temperature; Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip
Interventions: mymobility with Apple Watch; Other
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years and older
Enrollment: 6,559 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 26
States / cities: Fremont, California • Irvine, California • Redwood City, California + 23 more

Conditions: Total Hip Arthroplasty
Interventions: Real-time Instrumentation, Standard Total Hip Arthroplasty; Device · Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Osteoarthritis
Interventions: Ropivacaine infiltration and saline infusion., Ropivacaine infiltration and infusion., Normal Saline; Procedure
Lead sponsor: Trinity Health Of New England; Other
Eligibility: 18 Years to 80 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Pain, Postoperative, Opioid Use
Interventions: Acetaminophen; Drug
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 90 Years
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoarthritis of Hip
Interventions: Taperloc standard length stem, Taperloc short length stem; Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Blood Loss
Interventions: Intravenous Placebo, Intravenous Tranexamic Acid; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Mineola, New York

Conditions: Total Knee Replacement Surgery, Total Hip Replacement Surgery
Interventions: XPERIENCE Advanced Surgical Irrigation, Standard of Care Irrigation; Device · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Hip Arthroscopy
Interventions: Modified hip capsule side fixed slotted cannula, Modified bone graft delivery tool set; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 60 Years
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 2
States / cities: Boulder, Colorado • Englewood, Colorado

Conditions: Total Knee Arthroplasty, Total Hip Arthroplasty Revision, Total Knee Arthroplasty Revision
Interventions: Avance Solo Negative Pressure Wound Therapy; Device
Lead sponsor: Molnlycke Health Care AB; Industry
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 8
States / cities: Washington D.C., District of Columbia • Indianapolis, Indiana • Baltimore, Maryland + 5 more

Conditions: Antibiotic Prophylaxis Surgery
Interventions: CeFAZolin 1000 MG, Saline (0.9%, sterile, for infusion); Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Somerset, New Jersey

Conditions: Postoperative Cognitive Dysfunction
Interventions: Florbetapir F 18 (18F-AV-45), no intervention; Drug · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 65 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Total Knee Arthroplasty; Total Hip Arthroplasty
Interventions: Health Partner, Standard Care; Behavioral
Lead sponsor: DePuy Orthopaedics; Industry
Eligibility: 18 Years and older
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Plainsboro, New Jersey

Search by objective public record fields.

Capsulectomy vs Capsulotomy With Repair in Direct Anterior Total Hip Arthroplasty

Leisure Expectations About Physical Activity Study

Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT

MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)

Hip and Knee Scoring System to Predict Complication Rate and Candidacy for Total Hip and Knee Arthroplasty

Psoas Compartment Block Versus Periarticular Local Anesthetic for Total Hip Arthroplasty

Efficacy and Safety Study of 4975 in Patients Undergoing Total Hip Replacement

Medium Term Survivorship of Cementless THA Performed Using the Bone Preservation Tri-Lock Femoral Stem

Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip Replacement

Alexis Retractor in Total Hip Arthroplasty

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)

Observational Examination of Thermoregulation in Total Joint Arthroplasty

A Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform

Real-Time Instrument for Acetabular Shell Positioning

Local Anesthetic Infiltration and Infusion for Pain Control After Hip Replacement

IV vs. Oral Acetaminophen as a Component of Multimodal Analgesia After Total Hip Arthroplasty

The Viability of Short Stems in Total Hip Arthroplasty

Evaluating the Use of Tranexamic Acid (TXA) in Total Joint Arthroplasty

Xperience™ vs Normal Saline Irrigation Solution for Decreasing Bioburden After Primary Total Hip and Knee Arthroplasty

Modifications of Devices for Hip Arthroscopy

Interventional Study Exploring the Occurrence of Surgical Site Infections.

Efficacy and Safety of Intraosseous Antibiotic Prophylaxis in Total Hip Replacement

Effects of Brain Beta-Amyloid on Postoperative Cognition

Health Partner Evaluation at Princeton